LBFJul 233 min readThe Lilabean Foundation Funds Two Cutting-Edge Initiatives LBF is excited to announce funding for two new innovative projects in the second half of 2024.
LBFJul 82 min readMeet our 2024 LBF Fellow, Jian Li, PhDThe LBF Fellowship Fund is a program that was established in 2018 with a mission to fund the next generation of researchers in the...
LBFMay 93 min readA Conversation with LBF Scientific Advisor, Jessica Foster Join us for a conversation with Dr. Foster's about her pioneering work, and the profound motivation behind her dedication.
LBFApr 241 min read Day One Biopharmaceuticals Announces FDA approved of New Drug Application for relapsed or refractory pediatric low-grade glioma (pLGG)Yesterday Day One Biopharmaceuticals announced that the U.S. Food and Drug Administration (FDA) approved their New Drug Application (NDA)...
LBFSep 11, 20231 min readDay One Announces Updated FIREFLY-1 Data for TovorafenibToday, Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling New Drug Application (NDA) submission to U.S....
LBFJul 7, 20231 min readFIRST-OF-ITS-KIND OPEN-ANALYSIS PLATFORM FOR PEDIATRIC BRAIN TUMORS PROVIDES ROBUST DATA RESOURCE Collaboration among CHOP, Alex’s Lemonade Stand Foundation, the Pacific Pediatric Neuro-Oncology Consortium, and Children’s Brain Tumor...